MARKSANS
Marksans Pharma Limited
Healthcare
Share price
₹324
Market cap
₹14,698 Cr
1Y return
▲ 98%
A pharmaceutical formulation company engaged in the development and manufacture of a diverse range of drugs across multiple therapeutic areas for domestic and international markets. Marksans Pharma produces generic medications and branded formulations with a focus on quality and regulatory compliance. The company operates modern manufacturing facilities designed to meet stringent pharmaceutical production standards and global quality requirements.
Recent moves 2
Kotak Mutual FundIncreased
Kotak Mutual Fund increased its stake in Marksans Pharma from 1.13% to 1.14%, buying 20,101 shares for ₹53.69 lakh at ₹267.10 apiece.
Read more
UTI Mutual FundDecreased
UTI Mutual Fund decreased its stake in Marksans Pharma from 2.49% to 2.11%, selling 17,45,067 shares. The shares were valued at ₹46.59 Cr based on the closing price of ₹267.10 apiece.
Read more
Track the whales in Marksans Pharma Limited
Get alerted the moment a top investor buys or sells.
Get started